… , new treatment methods including target therapy … non-small-cell lung cancer. Chinese
Society of Clinical Oncology (CSCO) updates the CSCO guidelines for non-small-cell lung cancer …

… Abstract: Targeted therapy of epidermal growth factor … first-line treatment of advanced
EGFR-mutated non-small cell lung … : a meta-analysis based on updated individual patient data …

… in perioperative NSCLC have been updated. In terms of targeted therapy, the research and
… pembrolizumab versus standard of care in advanced non-small cell lung cancer previously …

… Health-related quality of life with carboplatin-paclitaxel or nab-paclitaxel with or without
pembrolizumab in patients with metastatic squamous non-small-cell lung cancer[J]. J Clin Oncol, …

… first-line treatment of advanced non-small cell lung cancer (… for advanced nonsquamous
nonsmall-cell lung cancer: updated … Target Oncol, 2015, 10(4):509-516. [31] Karayama M, Inui N, …

… on non-small cell lung cancer (… targeted therapy and immunotherapy have together
transformed the status of postoperative adjuvant therapy and established a new standard treatment …

… lung cancer, targeted therapy has greatly improved the survival and prognosis of patients with
advanced non-small cell lung cancer (… targeted drugs available and no standard treatment …

… is one of the most prevalence malignances, of which non-small cell lung cancer (NSCLC) …
Molecular target therapy is one of the most popular and promising field of NSCLC treatment, …

… various tumor types including non-small cell lung carcinoma … , as well as the updated clinical
progress of using anti-PD1 … for firstline treatment of advanced non-small-cell lung cancer[J]…

… latest research advances in imaging and biological markers for the clinical evaluation of lung
cancer treatment… treating non-small cell lung cancer[J]. Hebei Medicine, 2016, 22(1): 55-58. …